Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Effects of interleukin-13 on antifungal activity of human monocytes against Candida albicans.

Katsifa H, Tsaparidou S, Diza E, Gil-Lamaignere C, Walsh TJ, Roilides E.

FEMS Immunol Med Microbiol. 2001 Oct;31(3):211-7.

2.

Interleukin-4 suppresses antifungal activity of human mononuclear phagocytes against Candida albicans in association with decreased uptake of blastoconidia.

Roilides E, Kadiltsoglou I, Dimitriadou A, Hatzistilianou M, Manitsa A, Karpouzas J, Pizzo PA, Walsh TJ.

FEMS Immunol Med Microbiol. 1997 Oct;19(2):169-80.

3.

Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans.

Vázquez N, Walsh TJ, Friedman D, Chanock SJ, Lyman CA.

Infect Immun. 1998 Jan;66(1):145-50.

4.

Effects of macrophage colony-stimulating factor on antifungal activity of neonatal monocytes against Candida albicans.

Gioulekas E, Goutzioulis M, Farmakis C, Drossou V, Kremenopoulos G, Tsiouris J, Roilides E.

Biol Neonate. 2001;80(4):251-6.

PMID:
11641546
5.

Suppressive effects of interleukin-10 on human mononuclear phagocyte function against Candida albicans and Staphylococcus aureus.

Roilides E, Anastasiou-Katsiardani A, Dimitriadou-Georgiadou A, Kadiltsoglou I, Tsaparidou S, Panteliadis C, Walsh TJ.

J Infect Dis. 1998 Dec;178(6):1734-42.

PMID:
9815227
6.

Interleukin 10 suppresses phagocytic and antihyphal activities of human neutrophils.

Roilides E, Katsifa H, Tsaparidou S, Stergiopoulou T, Panteliadis C, Walsh TJ.

Cytokine. 2000 Apr;12(4):379-87.

PMID:
10805220
7.

Defective induction of interleukin-12 in human monocytes by germ-tube forms of Candida albicans.

Chiani P, Bromuro C, Torosantucci A.

Infect Immun. 2000 Oct;68(10):5628-34.

8.

Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages.

Netea MG, Gijzen K, Coolen N, Verschueren I, Figdor C, Van der Meer JW, Torensma R, Kullberg BJ.

Microbes Infect. 2004 Sep;6(11):985-9.

PMID:
15345229
9.
10.

Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase.

Tang N, Liu L, Kang K, Mukherjee PK, Takahara M, Chen G, McCormick TS, Cooper KD, Ghannoum M.

Infect Immun. 2004 May;72(5):2513-20.

12.

Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes.

Leijh PC, van den Barselaar MT, van Furth R.

Infect Immun. 1977 Aug;17(2):313-8.

13.

Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans.

Kim HS, Choi EH, Khan J, Roilides E, Francesconi A, Kasai M, Sein T, Schaufele RL, Sakurai K, Son CG, Greer BT, Chanock S, Lyman CA, Walsh TJ.

Infect Immun. 2005 Jun;73(6):3714-24.

14.
15.

Effect of intralipid on the phagocytic and microbicidal capacity of human monocytes in culture.

Padeh S, Shor R, Passwell JH.

J Pediatr Gastroenterol Nutr. 1987 Jul-Aug;6(4):575-80.

PMID:
3323443
16.

Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells.

Wei S, Serbousek D, McMillen S, Blanchard DK, Djeu JY.

J Immunol. 1991 Jan 1;146(1):337-42.

PMID:
1898605
17.

Enhancement of antibacterial superoxide-anion generation in human monocytes by fumaric acid esters.

Zhu K, Mrowietz U.

Arch Dermatol Res. 2005 Oct;297(4):170-6. Epub 2005 Sep 27.

PMID:
16187092
18.

Modulation of anti-Candida activity of human alveolar macrophages by interferon-gamma or interleukin-1-alpha.

Vecchiarelli A, Todisco T, Puliti M, Dottorini M, Bistoni F.

Am J Respir Cell Mol Biol. 1989 Jul;1(1):49-55.

PMID:
2516451
20.

Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.

Roilides E, Dimitriadou-Georgiadou A, Sein T, Kadiltsoglou I, Walsh TJ.

Infect Immun. 1998 Dec;66(12):5999-6003.

Supplemental Content

Support Center